Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00957801 · ClinicalTrials.gov registry record · Phase 4
Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men
A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00957801 is a Phase 4 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 29 participants.
The verdict
NCT00957801, a Phase 4 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
Skeletal muscle loss is a common consequence of aging and in some individuals reaches a level that compromises health and quality of life. Age-associated increases in cytokine and inflammatory signaling may be important contributors to this process. The investigators will assess the practical question of whether testosterone injection and gel application elicit similar responses. Resistance exercise will be used as a means of stimulating both inflammatory and anabolic responses in skeletal muscle. In order to assess the effects of testosterone on these responses, subjects will perform resistance exercise on two occasions separated by 7 days. The first session will be performed prior to the initiation of testosterone and/or medrol therapy and the second session will be performed after receiving therapy for 7 days.
Interventions
- DRUG Medrol
- DRUG Testosterone gel
- DRUG Testosterone injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00957801
The ClinicalTrials.gov registry entry for NCT00957801 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Medrol is the first listed.
NCT00957801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00957801 about?
NCT00957801 is a clinical study titled "Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men". Skeletal muscle loss is a common consequence of aging and in some individuals reaches a level that compromises health and quality of life. Age-associated increases in cytokine and inflammatory signaling may be important contributors to this process. The investigators will assess the practical quest...
What is the current status of trial NCT00957801?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2009-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00957801?
The interventions under investigation include: Medrol (DRUG), Testosterone gel (DRUG), Testosterone injection (DRUG).
Who is sponsoring clinical trial NCT00957801?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.